跳至主要内容
临床试验/NCT01199406
NCT01199406已完成4 期

Combined Preincisional Infiltration and Intraperitoneal Instillation of Levobupivacaine for Postoperative Pain Reduction After Laparoscopic Cholecystectomy; A Double-blind Placebo-controlled Randomised Clinical Trial

Meander Medical Center1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2009年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
80
试验地点
1
主要终点
Abdominal Pain in Visual Analogue Scale (VAS 0-100mm)

研究概览

简要总结

To determine the effect of combined intracutaneous infiltration and intraperitoneal instillation of 80 mL 0,125% levobupivacaine prior to the start of laparoscopic cholecystectomy on abdominal pain up to 24 hours after surgery.

详细描述

The primary endpoint of this study was postoperative abdominal pain as measured by a visual analogue scale (VAS), using a VAS lineal with a slide. The patient was asked to indicate a score from 0 to 100 corresponding to his or her pain. At 0.5, 2, 4, 8 and 24 hours after the surgical procedure the primary investigator visited the patient to obtain the VAS scores.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • between 18 and 80
  • ASA I or II
  • with symptomatic gallstone disease which requires elective laparoscopic cholecystectomy

排除标准

  • acute cholecystitis, cholangitis, severe acute pancreatitis, advanced liver cirrhosis or suspected gallbladder cancer,
  • a medical history of epilepsy, cardiac arrhythmias or chronic pain of any kind, - allergy to amid type drugs
  • pregnancy
  • patients suffering from hypotension or hypovolemia
  • infectious liver disease
  • conditions obstructing adequate pain scoring
  • patients using drugs that deduce function of the CYP3A4 or CYP1A2 system
  • patients having an American Society of Anaesthesiologists (ASA) classification of three or higher.

研究组 & 干预措施

normal saline

Placebo Comparator

80 mL 0.9% NaCl

干预措施: Levobupivacaine (Drug)

Levobupivacaine

Experimental

80mL 0.125% levobupivacaine

干预措施: Levobupivacaine (Drug)

结局指标

主要结局

Abdominal Pain in Visual Analogue Scale (VAS 0-100mm)

时间窗: 24 h postoperatively

Postoperative abdominal pain

次要结局

  • Shoulder pain(24 h)
  • Rescue Analgesics(24 h postoperatively)
  • adverse events caused by the investigational procedure or by levobupivacaine itself(Intra- and postoperative up to 24 hours)
  • Length of hospital stay(Maximum two weeks)
  • intra-operative complications including perforation of the gallbladder, bile duct injury, bowel injury and injury to vascular structures(intraoperative, 1 hour)
  • postoperative complications during hospitalisation(during hospitalisation (up to two weeks))

研究者

发起方
Meander Medical Center
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Pain Reduction After Cholecystectomy | 临床试验